Autotaxin in liver fibrosis.

[1]  K. Koike,et al.  Plasma lysophosphatidic acid levels and hepatocellular carcinoma , 2013, Hepatology.

[2]  S. Kōzuma,et al.  Serum autotaxin measurements in pregnant women: application for the differentiation of normal pregnancy and pregnancy-induced hypertension. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[3]  G. Giannelli,et al.  Tumor‐secreted lysophostatidic acid accelerates hepatocellular carcinoma progression by promoting differentiation of peritumoral fibroblasts in myofibroblasts , 2011, Hepatology.

[4]  Y. Inoue,et al.  Autotaxin as a novel serum marker of liver fibrosis. , 2011, Clinica chimica acta; international journal of clinical chemistry.

[5]  N. Sasahira,et al.  Specific increase in serum autotaxin activity in patients with pancreatic cancer. , 2011, Clinical biochemistry.

[6]  J. Prieto,et al.  Lysophosphatidic acid is a potential mediator of cholestatic pruritus. , 2010, Gastroenterology.

[7]  David A. Egan,et al.  Boronic acid-based inhibitor of autotaxin reveals rapid turnover of LPA in the circulation , 2010, Proceedings of the National Academy of Sciences.

[8]  Kyoko Noguchi,et al.  LPA receptors: subtypes and biological actions. , 2010, Annual review of pharmacology and toxicology.

[9]  M. Bollen,et al.  Rapid clearance of the circulating metastatic factor autotaxin by the scavenger receptors of liver sinusoidal endothelial cells. , 2009, Cancer letters.

[10]  S. Kōzuma,et al.  ORIGINAL ARTICLE: Expression of Autotaxin, an Ectoenzyme that Produces Lysophosphatidic Acid, in Human Placenta , 2009, American journal of reproductive immunology.

[11]  M. Kurokawa,et al.  Serum autotaxin measurement in haematological malignancies: a promising marker for follicular lymphoma , 2008, British journal of haematology.

[12]  J. Chun,et al.  Biological roles of lysophospholipid receptors revealed by genetic null mice: an update. , 2008, Biochimica et biophysica acta.

[13]  N. Afdhal,et al.  Diagnosis and quantitation of fibrosis. , 2008, Gastroenterology.

[14]  M. Nangaku,et al.  Validation of an autotaxin enzyme immunoassay in human serum samples and its application to hypoalbuminemia differentiation. , 2008, Clinica chimica acta; international journal of clinical chemistry.

[15]  M. Nangaku,et al.  Analysis of serum and urinary lysophospholipase D/autotaxin in nephrotic syndrome , 2008, Clinical chemistry and laboratory medicine.

[16]  J. Wain,et al.  The lysophosphatidic acid receptor LPA1 links pulmonary fibrosis to lung injury by mediating fibroblast recruitment and vascular leak , 2008, Nature Medicine.

[17]  M. Omata,et al.  Plasma lysophosphatidic acid level and serum autotaxin activity are increased in liver injury in rats in relation to its severity. , 2007, Life sciences.

[18]  Kazuhiro Nakamura,et al.  Both Plasma Lysophosphatidic Acid and Serum Autotaxin Levels are Increased in Chronic Hepatitis C , 2007, Journal of clinical gastroenterology.

[19]  H. Arai,et al.  Measurement of lysophospholipase D/autotaxin activity in human serum samples. , 2007, Clinical biochemistry.

[20]  Y. Kishi,et al.  Autotaxin Stabilizes Blood Vessels and Is Required for Embryonic Vasculature by Producing Lysophosphatidic Acid* , 2006, Journal of Biological Chemistry.

[21]  C. Mummery,et al.  Autotaxin, a Secreted Lysophospholipase D, Is Essential for Blood Vessel Formation during Development , 2006, Molecular and Cellular Biology.

[22]  Y. Kishi,et al.  Autotaxin Is Overexpressed in Glioblastoma Multiforme and Contributes to Cell Motility of Glioblastoma by Converting Lysophosphatidylcholine TO Lysophosphatidic Acid* , 2006, Journal of Biological Chemistry.

[23]  G. Reynolds,et al.  Induction of autotaxin by the Epstein-Barr virus promotes the growth and survival of Hodgkin lymphoma cells. , 2005, Blood.

[24]  Tanja Woyke,et al.  Gene expression profile of glioblastoma multiforme invasive phenotype points to new therapeutic targets. , 2005, Neoplasia.

[25]  B. Giepmans,et al.  The ins and outs of lysophosphatidic acid signaling , 2004, BioEssays : news and reviews in molecular, cellular and developmental biology.

[26]  H. Dralle,et al.  Expression, regulation and function of autotaxin in thyroid carcinomas , 2004, International journal of cancer.

[27]  D. Welch,et al.  Genetic Basis of Human Breast Cancer Metastasis , 2001, Journal of Mammary Gland Biology and Neoplasia.

[28]  Y. Inoue,et al.  Involvement of Rho/Rho kinase pathway in regulation of apoptosis in rat hepatic stellate cells. , 2003, American journal of physiology. Gastrointestinal and liver physiology.

[29]  S. Imamura,et al.  A novel colorimetric assay for the determination of lysophosphatidic acid in plasma using an enzymatic cycling method. , 2003, Clinica chimica acta; international journal of clinical chemistry.

[30]  Y. Inoue,et al.  Functional diversity between Rho-kinase- and MLCK-mediated cytoskeletal actions in a myofibroblast-like hepatic stellate cell line. , 2003, Biochemical and biophysical research communications.

[31]  R. Taguchi,et al.  Serum Lysophosphatidic Acid Is Produced through Diverse Phospholipase Pathways* , 2002, The Journal of Biological Chemistry.

[32]  K. Fukuzawa,et al.  Identification of Human Plasma Lysophospholipase D, a Lysophosphatidic Acid-producing Enzyme, as Autotaxin, a Multifunctional Phosphodiesterase* , 2002, The Journal of Biological Chemistry.

[33]  W. Moolenaar Lysophospholipids in the limelight , 2002, The Journal of cell biology.

[34]  G. Mills,et al.  Autotaxin has lysophospholipase D activity leading to tumor cell growth and motility by lysophosphatidic acid production , 2002, The Journal of cell biology.

[35]  Daniel L Baker,et al.  Plasma lysophosphatidic acid concentration and ovarian cancer. , 2002, JAMA.

[36]  J. Iredale,et al.  Gliotoxin stimulates the apoptosis of human and rat hepatic stellate cells and enhances the resolution of liver fibrosis in rats. , 2001, Gastroenterology.

[37]  S. Petersen,et al.  Identification of human renal cell carcinoma associated genes by suppression subtractive hybridization , 2001, British Journal of Cancer.

[38]  J. Iredale,et al.  Apoptosis of hepatic stellate cells: involvement in resolution of biliary fibrosis and regulation by soluble growth factors , 2001, Gut.

[39]  H. Ikeda,et al.  Lysophosphatidic acid enhances collagen gel contraction by hepatic stellate cells: association with rho-kinase. , 2000, Biochemical and biophysical research communications.

[40]  M. Sata,et al.  Histologic Improvement of Fibrosis in Patients with Hepatitis C Who Have Sustained Response to Interferon Therapy , 2000, Annals of Internal Medicine.

[41]  S. Friedman Molecular Regulation of Hepatic Fibrosis, an Integrated Cellular Response to Tissue Injury* , 2000, The Journal of Biological Chemistry.

[42]  T. Mammoto,et al.  Cooperation of fibronectin with lysophosphatidic acid induces motility and transcellular migration of rat ascites hepatoma cells. , 2000, Biochimica et biophysica acta.

[43]  S. Hirohashi,et al.  Cell motility mediated by rho and rho‐associated protein kinase plays a critical role in intrahepatic metastasis of human hepatocellular carcinoma , 1999, Hepatology.

[44]  M. Tsao,et al.  Autotaxin expression in non-small-cell lung cancer. , 1999, American journal of respiratory cell and molecular biology.

[45]  N. Kawada,et al.  In Vitro Migratory potential of rat quiescent hepatic stellate cells and its augmentation by cell activation , 1999, Hepatology.

[46]  Z. Zhao,et al.  Expression of autotaxin mRNA in human hepatocellular carcinoma. , 1999, Chinese medical journal.

[47]  J. Iredale,et al.  Mechanisms of spontaneous resolution of rat liver fibrosis. Hepatic stellate cell apoptosis and reduced hepatic expression of metalloproteinase inhibitors. , 1998, The Journal of clinical investigation.

[48]  M. Kawabata,et al.  Effects of lysophosphatidic acid on proliferation of stellate cells and hepatocytes in culture. , 1998, Biochemical and biophysical research communications.

[49]  F. Matsumura,et al.  Small GTP-binding Protein Rho Stimulates the Actomyosin System, Leading to Invasion of Tumor Cells* , 1998, The Journal of Biological Chemistry.

[50]  L. Liotta,et al.  Autotaxin, tumor motility-stimulating exophosphodiesterase. , 1997, Advances in enzyme regulation.

[51]  S. Friedman,et al.  Activation-dependent contractility of rat hepatic lipocytes in culture and in vivo. , 1993, The Journal of clinical investigation.

[52]  K. Tanikawa,et al.  Serum hyaluronate reflects hepatic sinusoidal capillarization. , 1993, Gastroenterology.

[53]  S. Nakamura,et al.  Defect of Fc receptors and phenotypical changes in sinusoidal endothelial cells in human liver cirrhosis. , 1993, The American journal of pathology.

[54]  L. Liotta,et al.  Identification, purification, and partial sequence analysis of autotaxin, a novel motility-stimulating protein. , 1992, The Journal of biological chemistry.

[55]  M. Rissel,et al.  Reversibility of hepatic fibrosis in experimentally induced cholestasis in rat. , 1990, The American journal of pathology.